BR0208719A - Uso de um composto - Google Patents

Uso de um composto

Info

Publication number
BR0208719A
BR0208719A BR0208719-7A BR0208719A BR0208719A BR 0208719 A BR0208719 A BR 0208719A BR 0208719 A BR0208719 A BR 0208719A BR 0208719 A BR0208719 A BR 0208719A
Authority
BR
Brazil
Prior art keywords
group
compound
substituents
phenyl
salts
Prior art date
Application number
BR0208719-7A
Other languages
English (en)
Inventor
Kazuo Sekiguchi
Katsumi Ikezono
Kazuhide Ohta
Takashi Maeda
Hisashi Nagamoto
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of BR0208719A publication Critical patent/BR0208719A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

"USO DE UM COMPOSTO". A invenção atual apresenta um agente útil e altamente seguro para a cura de doença crónica pulmonar obstrutiva, que contém, como o ingrediente efetivo, pelo menos um composto selecionado do grupo consistindo de derivados de tiazol e sais do mesmo, representado pela fórmula geral (1) onde R^ 1^ é um grupo fenila, o qual poderá ter 1 a 3 grupos alcoxila inferior como os substituintes do anel fenila; R^ 2^ é um grupo piridila o qual poderá ter 1 a 3 grupos carboxila como os substituintes no anel piridina.
BR0208719-7A 2001-07-24 2002-07-16 Uso de um composto BR0208719A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001222768 2001-07-24
PCT/JP2002/007221 WO2003009844A1 (en) 2001-07-24 2002-07-16 Use of thiazole deirvatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease

Publications (1)

Publication Number Publication Date
BR0208719A true BR0208719A (pt) 2004-07-20

Family

ID=19056195

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0208719-7A BR0208719A (pt) 2001-07-24 2002-07-16 Uso de um composto

Country Status (16)

Country Link
US (2) US20040147563A1 (pt)
EP (1) EP1411936B1 (pt)
KR (1) KR100566709B1 (pt)
CN (1) CN1267097C (pt)
AR (2) AR036179A1 (pt)
AT (1) ATE305299T1 (pt)
BR (1) BR0208719A (pt)
CA (1) CA2441804C (pt)
DE (1) DE60206391T2 (pt)
DK (1) DK1411936T3 (pt)
ES (1) ES2249596T3 (pt)
HK (1) HK1077216A1 (pt)
MX (1) MXPA04000620A (pt)
MY (1) MY128711A (pt)
TW (1) TWI302456B (pt)
WO (1) WO2003009844A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI394753B (zh) 2006-03-17 2013-05-01 Otsuka Pharma Co Ltd 新穎替妥牟拉（ｔｅｔｏｍｉｌａｓｔ）晶體
TWI436761B (zh) * 2006-06-19 2014-05-11 Otsuka Pharma Co Ltd 使用噻唑衍生物之方法
JP2011513203A (ja) * 2008-03-14 2011-04-28 大塚製薬株式会社 Ｍｍｐ−２及び／又はｍｍｐ−９阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2245660T3 (es) 1990-11-30 2006-01-16 Otsuka Pharmaceutical Co., Ltd. Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos.
AU4015497A (en) * 1996-08-26 1998-03-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Thiazole derivatives useful as selective inhibitors of pde-iv
MY128323A (en) * 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
US6727364B2 (en) * 2001-04-30 2004-04-27 The Procter & Gamble Company Triazole compounds useful in treating diseases associated with unwanted cytokine activity

Also Published As

Publication number Publication date
AR090619A2 (es) 2014-11-26
AR036179A1 (es) 2004-08-18
CA2441804C (en) 2007-05-08
CN1633295A (zh) 2005-06-29
DE60206391T2 (de) 2006-07-13
DE60206391D1 (de) 2006-02-09
WO2003009844A1 (en) 2003-02-06
EP1411936B1 (en) 2005-09-28
HK1077216A1 (en) 2006-02-10
CA2441804A1 (en) 2003-02-06
US20040147563A1 (en) 2004-07-29
KR20040028749A (ko) 2004-04-03
MY128711A (en) 2007-02-28
MXPA04000620A (es) 2004-06-25
TWI302456B (en) 2008-11-01
KR100566709B1 (ko) 2006-04-03
DK1411936T3 (da) 2005-12-27
EP1411936A1 (en) 2004-04-28
CN1267097C (zh) 2006-08-02
ES2249596T3 (es) 2006-04-01
US7932276B2 (en) 2011-04-26
US20080081828A1 (en) 2008-04-03
ATE305299T1 (de) 2005-10-15

Similar Documents

Publication Publication Date Title
BRPI0209216B8 (pt) derivados de quinolina e de quinazolina, composições farmacêuticas compreendendo os mesmos e seus usos
BRPI0000596B8 (pt) composto piridona, processo de produção do composto, composição farmacêutica, e uso do dito composto
NO983970L (no) Tricykliske forbindelser, deres fremstilling og anvendelse
AR004219A1 (es) Nuevos derivados de quinazolina, procedimientos para su preparacion, composiciones que los contienen y su uso en la preparacion de medicamentos,particularmente en el tratamiento de trastornos inflamatorios
HRP20050213A2 (en) 2,4-substituted indoles and their use as 5-ht6 modulators
BRPI0615111B8 (pt) composto, composição farmacêutica, e, uso do composto
MX9204137A (es) Derivados de 5-aril-isoxazol, composicion herbicida que los contiene y procedimiento para su preparacion.
EA200602170A1 (ru) Производные пиперидина, композиции на их основе, способы их применения
NO331013B1 (no) Nye forbindelser som er anti-inflammasjons, immunomodulerende og anti-proliferative midler, anvendelse av forbindelsene samt farmasoytisk preparat
BR9713417A (pt) Composto de açúcar, agente gelificante, composição de agente gelificante, processos para suas preparações e composição de gel.
BRPI0414514A (pt) uso de um composto, composto, e, composições farmacêuticas
BRPI0113162B8 (pt) compostos ariloxialquilaminas nao-imidazólicos e composição farmacêutica compreendendo os referidos compostos
BR0214455A (pt) Derivados benzotiazol
ATE503746T1 (de) Neue imidazolidinderivate
NO20004485L (no) Sykloalkenderivater, deres fremstilling og anvendelse
MX9400190A (es) Derivados de tiazolidindiona, metodo para su obtencion y composicion farmaceutica que los contiene.
DK0630366T3 (da) Substituerede heterocycliske derivater, der er nyttige som blodpladeaggregeringsinhibitorer
ES2126075T3 (es) Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa.
NO20001781L (no) 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse
NO964698D0 (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
ATE453389T1 (de) Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen
DK0404359T3 (da) Dibenzothiazepin-derivater, der er nyttige som antispasmodiske midler
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
BR0208719A (pt) Uso de um composto
BR0112243A (pt) Derivados de tetrazol

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]